ATE123028T1 - Phospholipase-a2-inhibitor, verfahren zu seiner herstellung und diesen enthaltende pharmazeutische oder veterinäre zusammensetzungen. - Google Patents

Phospholipase-a2-inhibitor, verfahren zu seiner herstellung und diesen enthaltende pharmazeutische oder veterinäre zusammensetzungen.

Info

Publication number
ATE123028T1
ATE123028T1 AT90304552T AT90304552T ATE123028T1 AT E123028 T1 ATE123028 T1 AT E123028T1 AT 90304552 T AT90304552 T AT 90304552T AT 90304552 T AT90304552 T AT 90304552T AT E123028 T1 ATE123028 T1 AT E123028T1
Authority
AT
Austria
Prior art keywords
phospholipase
inhibitor
compound
production
pharmaceutical
Prior art date
Application number
AT90304552T
Other languages
English (en)
Inventor
Tadasi Yoshida
Hitoshi Arita
Jun Ichi Shoji
Keizo Inoue
Shigeru Matsutani
Yoshimi Kawamura
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of ATE123028T1 publication Critical patent/ATE123028T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82Xanthenes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Botany (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT90304552T 1989-04-28 1990-04-26 Phospholipase-a2-inhibitor, verfahren zu seiner herstellung und diesen enthaltende pharmazeutische oder veterinäre zusammensetzungen. ATE123028T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1109939A JP2842613B2 (ja) 1989-04-28 1989-04-28 フォスフォリパーゼa▲下2▼阻害物質

Publications (1)

Publication Number Publication Date
ATE123028T1 true ATE123028T1 (de) 1995-06-15

Family

ID=14522941

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90304552T ATE123028T1 (de) 1989-04-28 1990-04-26 Phospholipase-a2-inhibitor, verfahren zu seiner herstellung und diesen enthaltende pharmazeutische oder veterinäre zusammensetzungen.

Country Status (7)

Country Link
US (1) US5011952A (de)
EP (1) EP0395418B1 (de)
JP (1) JP2842613B2 (de)
AT (1) ATE123028T1 (de)
DE (1) DE69019591T2 (de)
DK (1) DK0395418T3 (de)
ES (1) ES2075154T3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0547231T3 (da) * 1991-07-03 1996-09-16 Shionogi & Co Phospholipase-A2-inhibitor
CA2100640A1 (en) * 1992-07-23 1994-01-24 Shigeru Matsutani Substitute benzoate derivatives
GB9226724D0 (en) * 1992-12-22 1993-02-17 Xenova Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
JP2842613B2 (ja) 1999-01-06
US5011952A (en) 1991-04-30
EP0395418A1 (de) 1990-10-31
DK0395418T3 (da) 1995-08-07
EP0395418B1 (de) 1995-05-24
DE69019591D1 (de) 1995-06-29
JPH02286088A (ja) 1990-11-26
DE69019591T2 (de) 1996-01-25
ES2075154T3 (es) 1995-10-01

Similar Documents

Publication Publication Date Title
ATE121091T1 (de) Phospholipase a2-inhibitor, mikroorganismen, die diesen inhibitor erzeugen und mehrere verfahren zu seiner herstellung.
AU643489B2 (en) Antibacterial agents - II
HUT56379A (en) Process for producing a-norsteroid-3-carboxylic acid derivatives and compositions comprising such compounds
ATE181074T1 (de) Vinylen-azaindolderivate und verfahren zu ihrer herstellung
ATE135712T1 (de) Polypeptid, dessen verfahren zur herstellung und dieses enthaltende pharmazeutische zusammensetzung und deren benutzung
ATE52500T1 (de) Cyclohexenol-derivate, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses.
ATE211474T1 (de) Galanthamin derivate, verfahren zu ihrer herstellung und ihre verwendung als medikamente
AT380471B (de) Verfahren zur herstellung von neuen 2-oxoazetidin-derivate
IL75116A (en) Ethyl substituted-beta-carboxylates,process for the preparation thereof and pharmaceutical compositions containing the same
DE69106003D1 (de) Verfahren und zwischenprodukte zur herstellung von azabicyclo[2.2.2]octan-3-iminen.
ATE123028T1 (de) Phospholipase-a2-inhibitor, verfahren zu seiner herstellung und diesen enthaltende pharmazeutische oder veterinäre zusammensetzungen.
ATE214051T1 (de) Substituierte tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
ATE229006T1 (de) Verfahren zur herstellung von schwefelhaltigen imidazolderivaten und erhaltene zwischenprodukte
ATE173922T1 (de) 2-arylpropionsäure-zubereitungen und verfahren zu ihrer herstellung
ATE236895T1 (de) Ringannelierte dihydropyrane, verfahren zur herstellung sowie deren verwendung
DE59010896D1 (de) Verfahren zur Herstellung von 7-(3-Amino- sowie 3-Aminomethyl-1-pyrrolidinyl)-3-chinolon-carbonsäuren sowie -naphthyridoncarbonsäuren
BR9605027A (pt) Processo para preparar um carboxilato de b-trifluor-metila & b-insaturado
ATE224393T1 (de) Verfahren zur herstellung von cephalosporinen und zwischenverbindungen in diesem verfahren
DE69332707D1 (de) Verfahren zur Herstellung von 3-Vinylcephalosporinen
SE7906681L (sv) Ftalazonderivat
DE69905218D1 (de) Verfahren zur Herstellung von L-Allysin Acetal
DE69615869D1 (de) Eine zusammensetzung und ein verfahren zur foerderung der pflanzenproduktion und/oser zur eliminierung von unguenstigen umwelteinfluessen bei der pflanzenzucht
DE3882654D1 (de) Enzymhemmer und methode zu dessen herstellung.
ATE16696T1 (de) Verfahren zur herstellung von 3-alkyl-6-methylbeta-resorcylsaeureestern.
ATE179417T1 (de) Glyceraldehyd-3-pentanid und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee